O
14.97
0.60 (4.18%)
| Previous Close | 14.37 |
| Open | 14.45 |
| Volume | 5,164,217 |
| Avg. Volume (3M) | 13,858,845 |
| Market Cap | 4,310,718,976 |
| Price / Sales | 0.310 |
| Price / Book | 4.20 |
| 52 Weeks Range | |
| Earnings Date | 3 Feb 2026 |
| Profit Margin | 1.22% |
| Operating Margin (TTM) | 9.75% |
| Diluted EPS (TTM) | 0.400 |
| Quarterly Revenue Growth (YOY) | 42.20% |
| Quarterly Earnings Growth (YOY) | 55.20% |
| Total Debt/Equity (MRQ) | 26.88% |
| Current Ratio (MRQ) | 0.910 |
| Operating Cash Flow (TTM) | 1.22 B |
| Levered Free Cash Flow (TTM) | 1.06 B |
| Return on Assets (TTM) | 2.06% |
| Return on Equity (TTM) | 10.48% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Healthcare Plans (US) | Bullish | Bearish |
| Healthcare Plans (Global) | Bullish | Bearish | |
| Stock | Oscar Health, Inc. | Bullish | Bullish |
AIStockmoo Score
-0.1
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | -0.13 |
|
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan. |
|
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Investment Style | Small Value |
| % Held by Insiders | 4.13% |
| % Held by Institutions | 86.78% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Thrive Capital Management, Llc | 30 Sep 2025 | 6,343,617 |
| Glynn Capital Management Llc | 30 Sep 2025 | 2,856,025 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 25.00 (Piper Sandler, 67.00%) | Buy |
| Median | 17.00 (13.56%) | |
| Low | 11.00 (Wells Fargo, -26.52%) | Sell |
| Average | 17.60 (17.57%) | |
| Total | 1 Buy, 3 Hold, 1 Sell | |
| Avg. Price @ Call | 16.46 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| UBS | 09 Jan 2026 | 17.00 (13.56%) | Hold | 17.73 |
| 07 Nov 2025 | 12.00 (-19.84%) | Sell | 17.72 | |
| Barclays | 05 Jan 2026 | 18.00 (20.24%) | Hold | 16.57 |
| 10 Nov 2025 | 13.00 (-13.16%) | Sell | 14.61 | |
| Stephens & Co. | 11 Dec 2025 | 17.00 (13.56%) | Hold | 15.87 |
| Piper Sandler | 26 Nov 2025 | 25.00 (67.00%) | Buy | 18.16 |
| Wells Fargo | 13 Nov 2025 | 11.00 (-26.52%) | Sell | 13.95 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |